OR

Browse By

Developing E2F inhibitors as a potential therapeutic strategy for the treatment of head and neck squamous cell carcinoma (2004–2009)

Grant type:
Garnett Passe/Rodney Williams Memorial Foundation
Funded by:
Garnett Passe and Rodney Williams Memorial Foundation, The